Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Instead, they take away dollars that could be invested in American manufacturing and undermine biopharma R&D.
- Simplified Text
-
Foreign first pricing schemes take away dollars undermine biopharma R&D
- Confidence Score
- 0.800
- Claim Maker
- The author
- Context Type
- Blog
- Context Details
-
{ "impact": "Reduced investment in American manufacturing and biopharma R&D", "policy_type": "Foreign first pricing schemes" } - UUID
- 9fdb0069-0b73-4f8d-bb69-077f41f0102a
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:25 PM (1 day ago)
- Last Updated
- September 11, 2025 at 10:25 PM (1 day ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
143
claims
🔥
1 day ago
https://phrma.org/
PhRMA highlights the importance of a robust innovation ecosystem for medical advancements. They emphasize concerns about government price setting and its potential negative impact on future cures.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.